Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 9/20 | 0.78 |
| ▸ | XDH | P47989 | 2/20 | 0.57 |
| ▸ | JUN | P05412 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Picroside Ii SCHEMBL29367651 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL30387354 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL29425971 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL24209282 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL29426003 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Verproside SCHEMBL31619362 | 0.92 | HSP90AA1 (0.83) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Verproside SCHEMBL2449966 | 0.92 | HSP90AA1 (0.83) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| SCHEMBL29425954 | 0.89 | HSP90AA1 (0.60) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Catalposide SCHEMBL419598 | 0.88 | HSP90AA1 (1.00) | HSP90AA1XDHPOLBCTDSP1KDM4E | |
| SCHEMBL29642990 | 0.86 | HSP90AA1 (0.85) | HSP90AA1XDHKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017471-A1 | FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS | UNIV SHANGHAI TECHNOLOGY (CN) | 2022-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017471-A1 | FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS | PAICS, PFAS, OTC | HSP90AA1 4675/4885XDH 621/4885JUN 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.